CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-09-20 | NOVARTIS AG 10% owner | Sale | −1,551,896 | $19.42 | $30.1M | 4,051,002 |
| 2010-04-23 | NOVARTIS AG 10% owner | Purchase | +55,223 | $17.99 | $993K | 5,602,898 |
| 2009-05-06 | NOVARTIS AG 10% owner | Purchase | +65,922 | $17.50 | $1.2M | 5,547,675 |
| 2008-05-08 | NOVARTIS AG 10% owner | Purchase | +213,888 | $25.29 | $5.4M | 5,481,753 |
Page 1 of 1 · 4 trades